What is Jade Biosciences, Inc.?
operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. It develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 1.06B.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.